These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36339432)

  • 1. HDAC11, an emerging therapeutic target for metabolic disorders.
    Chen H; Xie C; Chen Q; Zhuang S
    Front Endocrinol (Lausanne); 2022; 13():989305. PubMed ID: 36339432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HDAC11 in obesity-related metabolic disorders: A critical review.
    Yang H; Chen L; Sun Q; Yao F; Muhammad S; Sun C
    J Cell Physiol; 2021 Aug; 236(8):5582-5591. PubMed ID: 33481312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury.
    Fan XD; Wan LL; Duan M; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(2):444-451. PubMed ID: 29655790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programming and Regulation of Metabolic Homeostasis by HDAC11.
    Sun L; Marin de Evsikova C; Bian K; Achille A; Telles E; Pei H; Seto E
    EBioMedicine; 2018 Jul; 33():157-168. PubMed ID: 29958910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes.
    Núñez-Álvarez Y; Suelves M
    FEBS J; 2022 May; 289(10):2771-2792. PubMed ID: 33891374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice.
    Bai P; Liu Y; Yang L; Ding W; Mondal P; Sang N; Liu G; Lu X; Ho TT; Zhou Y; Wu R; Birar VC; Wilks MQ; Tanzi RE; Lin H; Zhang C; Li W; Shen S; Wang C
    J Med Chem; 2023 Dec; 66(23):16075-16090. PubMed ID: 37972387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological function and small molecule inhibitors of histone deacetylase 11.
    Jia G; Liu J; Hou X; Jiang Y; Li X
    Eur J Med Chem; 2024 Oct; 276():116634. PubMed ID: 38972077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle.
    Hurtado E; Núñez-Álvarez Y; Muñoz M; Gutiérrez-Caballero C; Casas J; Pendás AM; Peinado MA; Suelves M
    FEBS J; 2021 Feb; 288(3):902-919. PubMed ID: 32563202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC11 is a regulator of diverse immune functions.
    Yanginlar C; Logie C
    Biochim Biophys Acta Gene Regul Mech; 2018 Jan; 1861(1):54-59. PubMed ID: 29222071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 11 as a key regulator of metabolism and obesity.
    Bhaskara S
    EBioMedicine; 2018 Sep; 35():27-28. PubMed ID: 30126820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC11: a rising star in epigenetics.
    Liu SS; Wu F; Jin YM; Chang WQ; Xu TM
    Biomed Pharmacother; 2020 Nov; 131():110607. PubMed ID: 32841898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family.
    Gao L; Cueto MA; Asselbergs F; Atadja P
    J Biol Chem; 2002 Jul; 277(28):25748-55. PubMed ID: 11948178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design.
    Khatun S; Prasad Bhagat R; Dutta R; Datta A; Jaiswal A; Halder S; Jha T; Amin SA; Gayen S
    Biochem Pharmacol; 2024 Jul; 225():116312. PubMed ID: 38788962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering novel scaffolds for specific HDAC11 inhibitors against metabolic diseases exploiting deep learning, virtual screening, and molecular dynamics simulations.
    Li J; Chen X; Liu R; Liu X; Shu M
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):129810. PubMed ID: 38340912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2.
    Cao J; Sun L; Aramsangtienchai P; Spiegelman NA; Zhang X; Huang W; Seto E; Lin H
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5487-5492. PubMed ID: 30819897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel histone deacetylase inhibitor unveils the role of HDAC11 in alleviating depression by inhibition of microglial activation.
    Baek SY; Lee J; Kim T; Lee H; Choi HS; Park H; Koh M; Kim E; Jung ME; Iliopoulos D; Lee JY; Kim J; Lee S
    Biomed Pharmacother; 2023 Oct; 166():115312. PubMed ID: 37567072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative status regulates HDAC11 mRNA abundance in nontransformed fibroblasts.
    Bagui TK; Sharma SS; Ma L; Pledger WJ
    Cell Cycle; 2013 Nov; 12(21):3433-41. PubMed ID: 24047695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific role of HDAC11 in kidney ischemia- and reperfusion-induced PAI-1 expression and injury.
    Kim JI; Jung KJ; Jang HS; Park KM
    Am J Physiol Renal Physiol; 2013 Jul; 305(1):F61-70. PubMed ID: 23657855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice.
    Bryant DT; Landles C; Papadopoulou AS; Benjamin AC; Duckworth JK; Rosahl T; Benn CL; Bates GP
    Sci Rep; 2017 Sep; 7(1):11900. PubMed ID: 28928414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness.
    Bi L; Ren Y; Feng M; Meng P; Wang Q; Chen W; Jiao Q; Wang Y; Du L; Zhou F; Jiang Y; Chen F; Wang C; Tang B; Wang Y
    Cancer Res; 2021 Apr; 81(8):2015-2028. PubMed ID: 33602787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.